Submitted Successfully!
To reward your contribution, here is a gift for you: A free trial for our video production service.
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Version Summary Created by Modification Content Size Created at Operation
1 -- 1364 2023-08-18 20:00:22 |
2 format correction Meta information modification 1364 2023-08-21 02:40:52 |

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Ferri Antonio, G.C.; Ramos Da Silva, A.S.; De Freitas, E.C.; Pauli, J.R. Time-Restricted Feeding and Weight Loss in Obesity. Encyclopedia. Available online: https://encyclopedia.pub/entry/48230 (accessed on 04 September 2024).
Ferri Antonio GC, Ramos Da Silva AS, De Freitas EC, Pauli JR. Time-Restricted Feeding and Weight Loss in Obesity. Encyclopedia. Available at: https://encyclopedia.pub/entry/48230. Accessed September 04, 2024.
Ferri Antonio, Guilherme Correia, Adelino Sanchez Ramos Da Silva, Ellen Cristini De Freitas, José Rodrigo Pauli. "Time-Restricted Feeding and Weight Loss in Obesity" Encyclopedia, https://encyclopedia.pub/entry/48230 (accessed September 04, 2024).
Ferri Antonio, G.C., Ramos Da Silva, A.S., De Freitas, E.C., & Pauli, J.R. (2023, August 18). Time-Restricted Feeding and Weight Loss in Obesity. In Encyclopedia. https://encyclopedia.pub/entry/48230
Ferri Antonio, Guilherme Correia, et al. "Time-Restricted Feeding and Weight Loss in Obesity." Encyclopedia. Web. 18 August, 2023.
Time-Restricted Feeding and Weight Loss in Obesity
Edit

Across the globe, obesity is a significant concern for public health, a disease characterized by excessive accumulation of body fat, with a negative impact on health. Time-restricted feeding (TRF), in which food accessibility is restricted to a variable period of 8–10 h, especially in the active phase, inducing a prolonged fasting period, is a strategy with potential effects in preventing obesity. Evidence in preclinical studies demonstrated that TRF attenuates the impacts of metabolic disturbances related to high-fat diet feeding in rodents. Through these discoveries, there has been growing interest in revealing the effects associated with TRF in preventing obesity and its comorbidities, as well as investigating its effects in humans. Although TRF is a promising alternative to reduce the impact of obesity, it is necessary to investigate the results on skeletal muscle tissue. Muscle tissue is important for body energy expenditure; however, caloric restriction can negatively impact protein turnover and induce loss of muscle mass, influencing the basal metabolic rate and weight loss.

obesity intermittent fasting skeletal muscle protein turnover

1. Introduction

The prevalence of obesity is a global public health problem with multifactorial etiology, including genetic, physiological, sociocultural, economic, and environmental factors [1]. Obesity is linked to numerous enduring health disorders, such as diabetes, hypertension, non-alcoholic fatty liver disease (NAFLD), cardiovascular disease, and various cancer types, as well as non-metabolic complications, including anxiety and depression [1].
Despite its constraints, addressing the health consequences of conditions associated with obesity often involves promoting weight loss to enhance both individual health and that of the population. However, weight loss achieved through restrictive diets triggers physiological and psychological “homeostatic pressures”, contributing to weight regain in over 90% of individuals [1].
In recognition of the limited effectiveness of restrictive dietary approaches with low long-term adherence, increasing emphasis has been placed on intermittent fasting nutritional strategies with time-restricted feeding (TRF). TRF is a fasting strategy with great applicability, showing excellent results for individuals who face difficulties in adhering to caloric restriction and who fear the possible side effects that a pharmacological treatment protocol may present [2][3][4].
It is established that obesity is correlated with impairments in muscle performance, resulting in an increased risk of developing functional disabilities, encompassing limitations in mobility, strength, postural control, and dynamic balance [5]. A possible negative result of TRF as a strategy to combat obesity could be the inhibition of muscle protein synthesis induced by post-prandial stimulation. As TRF decreases food intake, including protein, for some time, there is a hypothesis that this strategy could lead to a negative nitrogen balance and, consequently, to loss of muscle mass [6][7].

2. Time-Restricted Feeding

Intermittent fasting has been applied as an important tool for treating obesity and related diseases. This feeding protocol comprises several different forms of food intake, such as daily or weekly intake. Among the protocols studied, the three most relevant comprise complete fasting on alternate days (ADF): which involves deprivation of food on alternate days (fasting on days); modified alternating diets (MADF): which adopts different variations of ADF; and finally, time-restricted feeding (TRF): where food intake is restricted to specific times, with fasting for a long period. The scientific literature considers TRF as one of the most widely practiced fasting strategies to improve health and body composition through caloric restriction. TRF can range from 4 to 12 h, but an 8 h feeding period with a daily 16 h fast is typical [8][9].
Unlike most forms of intermittent fasting (IF), TRF does not necessarily have to be performed with a reduced caloric intake, as the potential benefits are linked to the time of day when the meals will be completed. The influence of the circadian system could explain the time-dependent effects observed in TRF interventions. The energy metabolism of glucose and lipids is regulated by the circadian cycle, which has an up and down regulation at different times of the day. For example, in humans, insulin sensitivity and the thermic effect of food exhibit greater prominence in the morning compared to the afternoon or evening. This observation implies that energy metabolism is optimized for food consumption during the daytime [10].
In a study conducted by Keim et al. (1997) involving women following a controlled weight-reduction regimen, it was observed that consuming the main meal in the morning (AM) resulted in more significant weight loss in comparison to finishing it in the evening (PM) [2]. Furthermore, consuming the main meal in the morning was associated with improved preservation of lean body mass. Thus, incorporating PM meals in a weight loss program may play a crucial role in reducing the loss of fat-free mass. However, for meals aligned with the circadian rhythm, increasing morning food intake may be more effective for weight loss [11]. This finding indicates that the efficacy of TRF interventions may rely on distinct mealtime strategies, necessitating different approaches for each specific objective.

3. TRF and Obesity

Lifestyle changes are the basis for obesity prevention and treatment strategies. These alterations include decreasing energy intake to approximately 500 kcal, increasing physical activity, and behavioral change techniques. Conventional calorie-restricted diets may have limited long-term success, with adherence levels typically lasting for 1 to 4 months, followed by significant weight regain in approximately one year [12].
As a way of preventing and treating obesity, TRF has been used as a fasting strategy with great applicability, offering a variety of nutritional therapy options for those who face difficulties in adhering to caloric restriction and who are concerned about possible side effects derived from a pharmacological treatment protocol. Preclinical studies provided scientific evidence demonstrating that the implementation of TRF can offer protection to obese rodents that are fed a high-fat diet. This protection is manifested through mitigated increases in body adiposity and reduced endocrine-metabolic disorders [13][14][15][16][17].
In this context, Hatori et al. (2012) studied whether obesity and metabolic diseases are due to a high-fat diet (HFD) or the interruption of metabolic cycles. For this, mice were fed ad-lib for 8 h TRF in the dark phase of an HFD for 8 h a day. Consequently, the researchers noted that mice following the TRF regimen consumed a similar amount of HFD calories as those with unrestricted access. However, the TRF group exhibited protection against obesity, hyperinsulinemia, fatty liver, and inflammation.
A study by Olsen et al. (2017) reported that animals with obesity induced by a high-fat diet submitted to a TRF regimen presented a restriction in weight gain when compared to free-fed animals, despite the same caloric intake levels. TRF also efficiently prevented excessive weight gain and metabolic diseases in mice without a circadian cycle in a food access protocol restricted to 10 h during the dark phase [10]. Overall, current evidence is positive, as TRF is associated with decreased body weight, improved glycemic homeostasis and insulin signaling, reduced inflammation, and a favorable effect on dyslipidemia [14][17][18][19]. Studies have also shown that TRF can prevent the development of NAFLD [10][13][20][21].
Following from the success of the effects of TRF when applied to animals, studies were developed using this dietary strategy in humans, which also showed efficient results in obesity. This fact was observed by Cienfuegos et al. (2020), where obese adults on a TRF protocol ranging from 4 to 8 h over 8 weeks successfully reduced weight, insulin resistance, and oxidative stress versus controls [22]. Positive data were also verified in a study by Jamshed et al. (2022), in obese individuals, where an 8 h food window was more effective for weight loss when compared to a group that performed a conventional food restriction protocol for 12 weeks [8].
In a study by He et al. (2022), the effects of a low-carbohydrate diet (LCD), an 8 h TRF protocol, and their combination were investigated over three months on body weight and abdominal fat area. The LCD treatment and the 8 h TRF protocol significantly reduced body weight and the subcutaneous fat area. However, only the TRF and the combined intervention reduced the visceral fat area (VFA), fasting glucose levels, uric acid (UA) levels, and improvements in dyslipidemia. In conclusion, an 8 h TRF can be regarded as an effective therapeutic approach for addressing metabolic syndrome [23].
Even with the benefits mentioned above, there are concerns regarding TRF and muscle mass homeostasis. A deficiency in caloric and protein intake can have a catabolic effect, in which degradation is more significant than protein synthesis, inducing loss of muscle mass. A possible negative result of TRF could be the inhibition of muscle protein synthesis induced by post-prandial stimulation.

References

  1. Bombak, A. Obesity, health at every size, and public health policy. Am. J. Public Health 2014, 104, 60–67.
  2. Keim, N.L.; Van Loan, M.D.; Horn, W.F.; Barbieri, T.F.; Mayclin, P.L. Weight Loss is Greater with Consumption of Large Morning Meals and Fat-Free Mass Is Preserved with Large Evening Meals in Women on a Controlled Weight Reduction Regimen. J. Nutr. 1997, 127, 75–82.
  3. Olsen, M.K.; Choi, M.H.; Kulseng, B.; Zhao, C.-M.; Chen, D. Time-restricted feeding on weekdays restricts weight gain: A study using rat models of high-fat diet-induced obesity. Physiol. Behav. 2017, 173, 298–304.
  4. Halpern, B.; Mendes, T.B. Intermittent fasting for obesity and related disorders: Unveiling myths, facts, and presumptions. Arch. Endocrinol. Metab. 2021, 65, 14–23.
  5. Tomlinson, D.J.; Erskine, R.M.; Morse, C.I.; Winwood, K.; Onambélé-Pearson, G. The impact of obesity on skeletal muscle strength and structure through adolescence to old age. Biogerontology 2016, 17, 467–483.
  6. Chow, L.S.; Manoogian, E.N.C.; Alvear, A.; Fleischer, J.G.; Thor, H.; Dietsche, K.; Wang, Q.; Hodges, J.S.; Esch, N.; Malaeb, S.; et al. Time-Restricted Eating Effects on Body Composition and Metabolic Measures in Humans who are Overweight: A Feasibility Study. Obesity 2020, 28, 860–869.
  7. Parr, E.B.; Kouw, I.W.K.; Wheeler, M.J.; Radford, B.E.; Hall, R.C.; Senden, J.M.; Goessens, J.P.B.; van Loon, L.J.C.; Hawley, J.A. Eight-hour time-restricted eating does not lower daily myofibrillar protein synthesis rates: A randomized control trial. Obesity 2022, 31, 116–126.
  8. Jamshed, H.; Steger, F.L.; Bryan, D.R.; Richman, J.S.; Warriner, A.H.; Hanick, C.J.; Martin, C.K.; Salvy, S.J.; Peterson, C.M. Effectiveness of Early Time-Restricted Eating for Weight Loss, Fat Loss, and Cardiometabolic Health in Adults with Obesity: A Randomized Clinical Trial. JAMA Intern. Med. 2022, 182, 953–962.
  9. Moro, T.; Tinsley, G.; Bianco, A.; Marcolin, G.; Pacelli, Q.F.; Battaglia, G.; Palma, A.; Gentil, P.; Neri, M.; Paoli, A. Effects of eight weeks of time-restricted feeding (16/8) on basal metabolism, maximal strength, body composition, inflammation, and cardiovascular risk factors in resistance-trained males. J. Transl. Med. 2016, 14, 290.
  10. Chaix, A.; Lin, T.; Le, H.D.; Chang, M.W.; Panda, S. Faculty Opinions recommendation of Time-Restricted Feeding Prevents Obesity and Metabolic Syndrome in Mice Lacking a Circadian Clock. Cell Metab. 2019, 29, 303–319.e4.
  11. Ruiz-Lozano, T.; Vidal, J.; de Hollanda, A.; Scheer, F.A.; Garaulet, M.; Izquierdo-Pulido, M. Timing of food intake is associated with weight loss evolution in severe obese patients after bariatric surgery. Clin. Nutr. 2016, 35, 1308–1314.
  12. Drummen, M.; Tischmann, L.; Gatta-Cherifi, B.; Adam, T.; Westerterp-Plantenga, M. Dietary Protein and Energy Balance in Relation to Obesity and Co-morbidities. Front. Endocrinol. 2018, 9, 443.
  13. Hatori, M.; Vollmers, C.; Zarrinpar, A.; DiTacchio, L.; Bushong, E.A.; Gill, S.; Leblanc, M.; Chaix, A.; Joens, M.; Fitzpatrick, J.A.; et al. Time-Restricted Feeding without Reducing Caloric Intake Prevents Metabolic Diseases in Mice Fed a High-Fat Diet. Cell Metab. 2012, 15, 848–860.
  14. Sherman, H.; Genzer, Y.; Cohen, R.; Chapnik, N.; Madar, Z.; Froy, O. Timed high-fat diet resets circadian metabolism and prevents obesity. FASEB J. 2012, 26, 3493–3502.
  15. Chaix, A.; Zarrinpar, A.; Miu, P.; Panda, S. Time-Restricted Feeding Is a Preventative and Therapeutic Intervention against Diverse Nutritional Challenges. Cell Metab. 2014, 20, 991–1005.
  16. Sundaram, S.; Yan, L. Time-restricted feeding reduces adiposity in mice fed a high-fat diet. Nutr. Res. 2016, 36, 603–611.
  17. Regmi, P.; Heilbronn, L.K. Time-Restricted Eating: Benefits, Mechanisms, and Challenges in Translation. iScience 2020, 23, 101161.
  18. Melkani, G.C.; Panda, S. Time-restricted feeding for prevention and treatment of cardiometabolic disorders. J. Physiol. 2017, 595, 3691–3700.
  19. Aouichat, S.; Chayah, M.; Bouguerra-Aouichat, S.; Agil, A. Time-Restricted Feeding Improves Body Weight Gain, Lipid Profiles, and Atherogenic Indices in Cafeteria-Diet-Fed Rats: Role of Browning of Inguinal White Adipose Tissue. Nutrients 2020, 12, 2185.
  20. Chung, H.; Chou, W.; Sears, D.D.; Patterson, R.E.; Webster, N.J.; Ellies, L.G. Time-restricted feeding improves insulin resistance and hepatic steatosis in a mouse model of postmenopausal obesity. Metabolism 2016, 65, 1743–1754.
  21. Vieira, R.F.L.; Muñoz, V.R.; Junqueira, R.L.; Oliveira, F.; Gaspar, R.C.; Nakandakari, S.C.B.R.; Costa, S.d.O.; Torsoni, M.A.; da Silva, A.S.; Cintra, D.E.; et al. Time-restricted feeding combined with aerobic exercise training can prevent weight gain and improve metabolic disorders in mice fed a high-fat diet. J. Physiol. 2022, 600, 797–813.
  22. Cienfuegos, S.; Gabel, K.; Kalam, F.; Ezpeleta, M.; Wiseman, E.; Pavlou, V.; Lin, S.; Oliveira, M.L.; Varady, K.A. Effects of 4- and 6-h Time-Restricted Feeding on Weight and Cardiometabolic Health: A Randomized Controlled Trial in Adults with Obesity. Cell Metab. 2020, 32, 366–378.e3.
  23. He, M.; Wang, J.; Liang, Q.; Li, M.; Guo, H.; Wang, Y.; Deji, C.; Sui, J.; Wang, Y.-W.; Liu, Y.; et al. Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: A randomized trial. Cell Rep. Med. 2022, 3, 100777.
More
Information
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : , , ,
View Times: 193
Revisions: 2 times (View History)
Update Date: 21 Aug 2023
1000/1000
ScholarVision Creations